Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00807794 · ClinicalTrials.gov registry record · Phase 1
A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00807794 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 13 participants.
The verdict
NCT00807794, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
To evaluate the clinical safety of different doses of MEDI-507 through day 33.
Interventions
- DRUG MEDI-507
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 1997-02 |
| Est. Completion | 1998-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00807794
The ClinicalTrials.gov registry entry for NCT00807794 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDI-507 is the first listed.
NCT00807794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00807794 about?
NCT00807794 is a clinical study titled "A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection". To evaluate the clinical safety of different doses of MEDI-507 through day 33.
What is the current status of trial NCT00807794?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 1997-02. Estimated completion is 1998-01.
What interventions are being tested in trial NCT00807794?
The interventions under investigation include: MEDI-507 (DRUG).
Who is sponsoring clinical trial NCT00807794?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.